FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes

[News Reader]

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

More... (http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm263964.htm)